LD Arnold… - Archives of internal medicine, 2011 - Am Med Assoc The benefit of BSO is well established for those with a known genetic risk for ovarian and breast cancer (eg, BRCA1 [GenBank U14680] and BRCA2 [GenBank U43746] carriers). 3-4 However, there is a lack of consistent scientific evidence in support of (or against) ... Cited by 1 - Related articles - All 3 versions
VL Jacoby, D Grady, J Wactawski-Wende… - Archives of internal …, 2011 - Am Med Assoc Methods This is a prospective cohort of 25 448 postmenopausal women aged 50 to 79 years enrolled in the Women's Health Initiative Observational Study who had a history of hysterectomy and BSO (n = 14 254 [56.0%]) or hysterectomy with ovarian conservation (n = 11 194 ... Cited by 3 - Related articles - All 3 versions
GX Cai, Y Xu, DF Tang, P Lian, JJ Peng… - Colorectal …, 2011 - Wiley Online Library Results Both univariate and multivariate analyses showed that tumor stage and adjuvant chemotherapy were the only two significant clinical factors that affected the 5-year overall survival of patients (P < 0.01). There was no significant difference in the 5-year overall survival between ... Related articles - All 3 versions
CB Powell, L Chen, J McLennan… - International Journal …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > Current ... Related articles - All 4 versions
HB Nichols, K Visvanathan… - American Journal of …, 2011 - Oxford Univ Press Bilateral oophorectomy is often performed during hysterectomy for benign conditions and can reduce breast cancer risk by 20%–50% when performed at younger ages. Accuracy of estimating the decrease in breast cancer risk associated with bilateral oophorectomy could be ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
